Evaluation of Plasma Cystatin C Depending on Physiological Factors in Healthy Iraqi People
DOI:
https://doi.org/10.46966/msjar.v5i2.207Keywords:
Age, cystatin-C, Kidney disease , ObesityAbstract
Background: Cystatin C is a small protein formed by nucleated cells and has gained significant attention as a potential test for various health conditions, including cardiovascular diseases and impaired kidney functions. Although existing research on cystatin C levels in different populations, there remains a gap in understanding its variations in healthy Iraqi individuals, particularly concerning gender, age, and body mass index (BMI). Aim: This study addresses this gap by evaluating the evolution of plasma cystatin C levels in 180 healthy Iraqi volunteers. Methods: the samples were categorized based on age, gender, and obesity status. Results: showed no significant difference (p-value ≤ 0.05) according to gender with the mean value of Cystatin C as 0.8511 pg/ml and 0.7881 pg/ml in male and female groups, respectively. The result showed gradually elevated levels in Cystatin C according to age, when Cystatin C values were 0.6676 ± 0.1918 pg/ml, 0.8339 ± 0.3416 pg/ml, 0.8442 ± 0.3422 pg/ml, 0.8930 ± 0.3471 pg/ml, 1.103 ± 0.3356 pg/ml in 40s, 50s, 60s, 70s, and 80s groups, respectively (p-value ≤ 0.05). Also, the result showed significant differences (p-value ≤ 0.05) in Cystatin C levels according to BMI with mean values of 0.7578 ± 0.1036 pg/ml, 0.7999 ± 0.3176 pg/ml, 0.9218 ± 0.2629 pg/ml, 1.0280 ± 0.4693 pg/ml in normal BMI, overweight, obese, and extremely obese, respectively. Conclusion: the study concludes that age and BMI significantly influence serum cystatin C levels in healthy people. These findings provide valuable insights into the physiological factors affecting cystatin C levels in the Iraqi population and underscore the need for finding reference values tailored to this specific demographic.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Ahmed Ghdhban Al-Ziaydi

This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.


















